Curanex Pharmaceuticals Inc Interest Expense Nonoperating
Curanex Pharmaceuticals Inc (CURX) reported Interest Expense Nonoperating of $8.54 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- Curanex Pharmaceuticals Inc interest expense nonoperating for the quarter ending 2025-12-31 was $0.00.
- Curanex Pharmaceuticals Inc interest expense nonoperating for the quarter ending 2025-09-30 was $4.09K.
- Curanex Pharmaceuticals Inc interest expense nonoperating for the quarter ending 2025-06-30 was $3.09K.
- Curanex Pharmaceuticals Inc interest expense nonoperating for the quarter ending 2025-03-31 was $1.36K.
- Curanex Pharmaceuticals Inc interest expense nonoperating for fiscal 2025 was $8.54K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $4.09K derived: sum of 2 quarters · filed 2026-03-30 | $7.18K derived: sum of 3 quarters · filed 2026-08-14 | $8.54K 10-K · filed 2026-03-30 |
| 2025-09-30 | $4.09K 10-Q · filed 2025-11-17 | $7.18K derived: sum of 2 quarters · filed 2026-08-14 | $8.54K 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $3.09K 10-Q · filed 2026-08-14 | $4.45K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $1.36K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |